Aptevo Therapeutics Inc. Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities
Aptevo Therapeutics Inc. (APVO) had Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities of $878.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities · last filed 2017-11-13
- 2017-09-30: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities $878.00K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities |
|---|---|
| 2017-09-30 | $878.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |